Evaluating metastasis in cervical lymph nodes of papillary thyroid carcinoma: the value of combining imaging features and thyroglobulin
Year: 2026
Type: article
Study design: Observational Study
Abstract: Papillary thyroid carcinoma (PTC) accounts for > 80% of thyroid malignancies, with lateral cervical lymph node metastasis (LNM) (levels II–V) occurring in 20–50% of cases. Notably, LNM is a key prognostic factor which increases locoregional recurrence risk (up to 30%) and may worsen survival in high-risk patients. Therefore, early detection of metastasis is critical for timely intervention. The study aims to evaluate the value of combining imaging features and fine-needle aspiration thyroglobulin (FNA-Tg) in assessing lateral cervical lymph node metastasis in PTC. A retrospective analysis of 182 PTC patients (January 2021–February 2022) was conducted. Preoperative ultrasound, computed tomography (CT), and FNA-Tg tests were performed, with pathological results as the gold standard. The diagnostic efficacy of different methods was compared. Among 223 suspected lymph nodes, 153 were metastatic and 70 were non-metastatic. No significant difference in general characteristics was observed ( P > 0.05), but tumor grade, shape, cortical echogenicity, and cystic degeneration differed significantly between the two groups ( P < 0.05). FNA-Tg and FNA-TgAb levels were higher in metastatic lymph nodes and positively correlated with metastasis (r1 = 0.652, r2 = 0.574; P < 0.05). The non-metastatic group showed a negative correlation (r1=-0.469, r2=-0.584; P < 0.05). The combination of imaging and FNA-Tg yielded an AUC of 0.952 (95% CI: 0.890–0.985), with sensitivity and specificity of 98.13% and 94.33%, respectively, outperforming single methods ( P < 0.05). Combining imaging features with FNA-Tg significantly improves the diagnostic accuracy for lateral cervical lymph node metastasis in PTC, offering a reliable tool for clinical decision-making. The research plan and data collection have been reviewed and approved by the Ethics Committee of Affiliated Hospital of Panzhihua University. (No. 2022-12-025).
Source: BMC Surgery
Institutions: Panzhihua University, National University of Malaysia
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,090
OpenAlex ID: W7234968702
